These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24698468)

  • 21. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.
    Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S
    Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of evidence-based medication use on long-term survival in patients hospitalised for heart failure in Western Australia.
    Teng TH; Hung J; Finn J
    Med J Aust; 2010 Mar; 192(6):306-10. PubMed ID: 20230346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.
    Gislason GH; Abildstrom SZ; Rasmussen JN; Rasmussen S; Buch P; Gustafsson I; Friberg J; Gadsbøll N; Køber L; Stender S; Madsen M; Torp-Pedersen C
    Scand Cardiovasc J; 2005 Apr; 39(1-2):42-9. PubMed ID: 16097413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of cardioprotective medication prescription in incident hemodialysis patients.
    Sood MM; Battistella M; Lok CE
    Int Urol Nephrol; 2009 Dec; 41(4):1021-7. PubMed ID: 19653115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.
    Vardeny O; Uno H; Braunwald E; Rouleau JL; Gersh B; Maggioni AP; Domanski M; Pfeffer MA; Solomon SD;
    Am J Cardiol; 2011 Jun; 107(12):1705-9. PubMed ID: 21507365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
    Berger AK; Duval S; Krumholz HM
    J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography.
    Mazar M; Schair B; Aronow WS; Khalique O; Lehrman SG
    Am J Ther; 2008; 15(5):458-60. PubMed ID: 18806522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of obesity on in-hospital treatment for acute coronary syndrome complicated by new-onset heart failure.
    Wu AH; Eagle KA; Froehlich JB; Montgomery DG; Kline-Rogers E; Aaronson KD
    Coron Artery Dis; 2013 Jun; 24(4):279-84. PubMed ID: 23511946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Planer D; Mehran R; Ohman EM; White HD; Newman JD; Xu K; Stone GW
    Circ Cardiovasc Interv; 2014 Jun; 7(3):285-93. PubMed ID: 24847016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years.
    Kragholm K; Halim SA; Yang Q; Schulte PJ; Hochman JS; Melloni C; Mahaffey KW; Moliterno DJ; Harrington RA; White HD; Armstrong PW; Ohman EM; Van de Werf F; Tricoci P; Alexander JH; Giugliano RP; Newby LK
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):357-67. PubMed ID: 26152683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Flaherty JD; Rossi JS; Fonarow GC; Nunez E; Stough WG; Abraham WT; Albert NM; Greenberg BH; O'Connor CM; Yancy CW; Young JB; Davidson CJ; Gheorghiade M
    Am Heart J; 2009 Jun; 157(6):1018-25. PubMed ID: 19464412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.
    Bainey KR; Armstrong PW; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Zhao X; Schwamm LH; Bhatt DL
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):227-35. PubMed ID: 24569634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry.
    Chow BJ; Small G; Yam Y; Chen L; McPherson R; Achenbach S; Al-Mallah M; Berman DS; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Cheng VY; Chinnaiyan K; Cury R; Delago A; Dunning A; Feuchtner G; Hadamitzky M; Hausleiter J; Karlsberg RP; Kaufmann PA; Kim YJ; Leipsic J; LaBounty T; Lin F; Maffei E; Raff GL; Shaw LJ; Villines TC; Min JK;
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):981-9. PubMed ID: 25676000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion.
    Hwang JK; Yang JH; Hwang JW; Jang WJ; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Choi SH
    Medicine (Baltimore); 2016 Jul; 95(30):e4300. PubMed ID: 27472704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.